Macquarie Group
CMD

Macquarie Group’s Cantel Medical Corporation CMD Stock Holding History

Macquarie Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,377
Closed -$110K – 2585
2021
Q1 		$110K Sell
1,377
-462
-25% -$36.1K ﹤0.01% 1880
2020
Q4 		$145K Hold
1,839
– – ﹤0.01% 1779
2020
Q3 		$81K Hold
1,839
– – ﹤0.01% 1835
2020
Q2 		$81K Buy
+1,839
New +$68.6K ﹤0.01% 1816
2018
Q4 		– Sell
-700
Closed -$64K – 2396
2018
Q3 		$64K Buy
700
+200
+40% +$19.1K ﹤0.01% 1682
2018
Q2 		$49K Sell
500
-400
-44% -$44.7K ﹤0.01% 1953
2018
Q1 		$100K Buy
900
+100
+13% +$11.2K ﹤0.01% 1875
2017
Q4 		$82K Buy
800
+400
+100% +$39.8K ﹤0.01% 1930
2017
Q3 		$38K Buy
+400
New +$31.6K ﹤0.01% 2033

Macquarie Group's CMD Position: Q2 2021 in Review

Macquarie Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,377 shares — an estimated $110K sold.

Macquarie Group first reported a position in CMD in Q3 2017 and held it in 9 quarters. The position peaked at $145K in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Macquarie Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Macquarie Group sold 1,377 Cantel Medical Corporation shares in Q2 2021, an estimated $110K.
  • Macquarie Group first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 9 quarters.
  • Macquarie Group's Cantel Medical Corporation position peaked at $145K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Macquarie Group's 13F filing for Q2 2021, filed 13 Aug 2021.